Mohammed Z.H. Farooqui
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 23
-
- Lymphoma Diagnosis and Treatment 13
- Genetic factors in colorectal cancer 4
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments 8
- Multiple Myeloma Research and Treatments 6
- Oncology top 10%
- Colorectal Cancer Treatments and Studies 5
- Peptidase Inhibition and Analysis 3
-
- Advanced Breast Cancer Therapies 5
- Co-authors
- Patricia MarinelloCornelis J.A. PuntTae Won KimBenny Vittrup JensenLars Henrik JensenThierry AndréDung T. LeChristelle de la Fouchardière
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Mohammed Z.H. Farooqui
34 papers receiving 713 citations
Peers
Comparison fields: 5 of 53
- Genetics 225
- Pathology and Forensic Medicine 358
- Hematology 198
- Oncology 428
- Immunology 143
Countries citing papers authored by Mohammed Z.H. Farooqui
This map shows the geographic impact of Mohammed Z.H. Farooqui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Z.H. Farooqui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Z.H. Farooqui more than expected).
Fields of papers citing papers by Mohammed Z.H. Farooqui
This network shows the impact of papers produced by Mohammed Z.H. Farooqui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Z.H. Farooqui. The network helps show where Mohammed Z.H. Farooqui may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mohammed Z.H. Farooqui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 5 | |
| 8 | 2023 | 29 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 1 | |
| 12 | 2022 | 12 | |
| 13 | 2022 | 2 | |
| 14 | 2022 | 30 | |
| 15 | 2021 | 135 | |
| 16 | 2021 | 43 | |
| 17 | 2020 | 6 | |
| 18 | 2020 | 2 | |
| 19 | 2019 | 63 | |
| 20 | 2016 | 1 |
About Mohammed Z.H. Farooqui
Mohammed Z.H. Farooqui is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 36 papers that have together received 719 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (23 papers), Lymphoma Diagnosis and Treatment (13 papers), Chronic Myeloid Leukemia Treatments (8 papers), Multiple Myeloma Research and Treatments (6 papers), Advanced Breast Cancer Therapies (5 papers), Colorectal Cancer Treatments and Studies (5 papers), Genetic factors in colorectal cancer (4 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Genetics (225 citations), Pathology and Forensic Medicine (358 citations) and Hematology (198 citations). Mohammed Z.H. Farooqui has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Patricia Marinello, Cornelis J.A. Punt, Tae Won Kim, Benny Vittrup Jensen, Lars Henrik Jensen, Thierry André, Dung T. Le, Christelle de la Fouchardière, Rocio García‐Carbonero and Takayuki Yoshino. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.